Latest Share Chat

REMOVE ADS

Abingdon Healt. Share News (ABDX)

Abingdon Healt. Information

Share Price Information for Abingdon Healt. (ABDX)

Share Price is delayed by 15 minutes

Get Live Data

12.75 0.50 (4.08%)

Bid:

12.50

Ask:

13.00

Spread: 0.50 (4.00%)

Market Cap: £32.01m

Last checked at -

Intraday Abingdon Healt. Share Chart

REMOVE ADS

Abingdon Healt. News

Abingdon Health stock up on partnership with Senzo on diagnostic tests

(Alliance News) - Abingdon Health PLC on Monday announced it has signed a partnership agreement with Senzo Health Ltd to provide contract development ...

Abingdon Health strikes strategic partnership with Senzo

(Sharecast News) - Diagnostic tests manufacturer Abingdon Health has entered into a strategic partnership with lateral flow technology group Senzo.

IN BRIEF: Abingdon Health granted additional patent AppDx LFT reader

Abingdon Health PLC - lateral flow contract development and manufacturing company - On Tuesday, announces the granting of an additional patent for its...

TRADING UPDATES: Abingdon Health optimistic; Chamberlin expects growth

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

LONDON MARKET MIDDAY: Stocks lower; Sunak looks to sell protocol deal

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday, as investors wait to hear whether UK Prime Minister Rishi Sunak has b...

AIM WINNERS & LOSERS: Safestay rises as young people travel again

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

TRADING UPDATES: Anglo Asian Mining reports mineral resource estimate

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Abingdon Health confident moving into 2023

(Sharecast News) - Diagnostic test developer and manufacturer Abingdon Health said in an update on Monday that its outlook moving into 2023 remained u...